Skip to content
ppharmaranks
Menu
Class IIOngoing

Glycopyrrolate Oral Solution recall

FDA recall D-0741-2026 · initiated Jul 14, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jul 29, 2026How we research

Precision Dose Inc. recalled Glycopyrrolate Oral Solution in Jul 2026 — an FDA Class II recall (D-0741-2026) because Failed Impurities/Degradation Specifications.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Failed Impurities/Degradation Specifications

An impurity above the accepted limit

A by-product of manufacturing or storage exceeded the limit the FDA accepts. Nitrosamines are the common example: the concern is long-term exposure, not immediate danger from one dose.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot # 506033, Exp Date: 11/30/2026.

Quantity recalled: N/A

Details

Product
Glycopyrrolate Oral Solution, 1 mg/5 mL, delivers 5 mL, Rx only, Pkg: Precision Dose, Inc, S. Beloil, IL 61080, unit-dose oral syringes, NDCs 68094-073-01 (oral syringe) and 68094-073-58 (case).
Recalling company
Precision Dose Inc
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
US Nationwide.
Initiated
Jul 14, 2026
FDA report date
Jul 29, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Glycopyrrolate Oral Solution recalled?
Precision Dose Inc. recalled Glycopyrrolate Oral Solution in Jul 2026 — an FDA Class II recall (D-0741-2026) because Failed Impurities/Degradation Specifications. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Glycopyrrolate Oral Solution recalled?
Per the FDA enforcement record, the reason for recall D-0741-2026 was: Failed Impurities/Degradation Specifications
Is a recalled Glycopyrrolate Oral Solution dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Glycopyrrolate Oral Solution are affected?
Distributed: US Nationwide.. The recall covers these lots — Lot # 506033, Exp Date: 11/30/2026.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0741-2026.

Source: openFDA Drug Enforcement record D-0741-2026

← All drug recalls